Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
LACTOSE (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -8.5666.44-5.7996.48-31.65

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is -8.56 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-8.56
Mar202466.44
Mar2023-5.79
Mar202296.48
Mar2021-31.65

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2025 -8.56
Negative
Mar2024 66.44
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹120.1 Cr -6.9% -5.4% -42.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-6.9%

-5.4%

-42.8%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses